Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular vancomycin in hip hemiarthroplasty
IRCT20230703058652N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2023
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Superficial surgical site infection and Deep surgical site infection. Started Jun 2023; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20230703058652N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230703058652N1.